The House Appropriations Committee approved language in a bill that would direct the FDA to complete its review by December of languishing applications for sunscreen ingredients. A bill in the Senate called the Sunscreen Innovation Act would give the FDA 11 months to decide on new applications and eight months for existing applications.

Full Story:
Hill, The

Related Summaries